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  13 
Abstract 14 
 15 
The incidences of skin cancers resulting from chronic ultraviolet radiation (UVR) exposure 16 
are on the incline both in Australia and globally. Hence, the cellular and molecular pathways 17 
associated with UVR-induced photocarcinogenesis urgently need to be elucidated, in order to 18 
develop more robust preventative and treatment strategies against skin cancers. In vitro 19 
investigations into the effects of UVR (in particular the highly-mutagenic UVB wavelength) 20 
have, to date, mainly involved the use of cell culture and animal models. However, these 21 
models possess biological disparities to native skin, which to some extent have limited their 22 
relevance to the in vivo situation. To address this, we characterised a 3-dimensional, tissue-23 
engineered human skin equivalent (HSE) model (consisting of primary human keratinocytes 24 
cultured on a dermal-derived scaffold) as a representation of a more physiologically-relevant 25 
platform to study keratinocyte responses to UVB. Significantly, we demonstrate that this 26 
model retains several important epidermal properties of native skin. Moreover, UVB-27 
irradiation of the HSE constructs was shown to induce key markers of photodamage in the 28 
HSE keratinocytes, including the formation of cyclobutane pyrimidine dimers, the activation 29 
of apoptotic pathways, the accumulation of p53 and the secretion of inflammatory cytokines. 30 
Importantly, we also demonstrate that the UVB-exposed HSE constructs retain the capacity 31 
for epidermal repair and regeneration following photodamage. Together, our results 32 
demonstrate the potential of this skin equivalent model as a tool to study various aspects of 33 
the acute responses of human keratinocytes to UVB radiation damage.  34 
  35 
  36 
Introduction 37 
The skin’s epidermis forms the frontline of protection against environmental hazards, 38 
including the ultraviolet radiation (UVR) wavelength subtypes UVA (320-400 nm), UVB 39 
(290-320 nm) and UVC (200-290 nm). Chronic, unprotected exposure to high levels of UVR 40 
and predisposing genetic risk factors have been shown to increase the likelihood of skin 41 
cancer development (1-3). Consequently, populations in countries that experience extreme 42 
levels of solar UVR experience the highest rates of skin cancers (4). In Australia, for 43 
example, non-melanoma skin cancers (NMSC), resulting from the carcinogenic 44 
transformation of epidermal keratinocytes, represent the most frequently diagnosed cancer 45 
type (4, 5). Furthermore, the treatment of NMSCs also represents the largest financial burden 46 
on the Australian healthcare system (6). 47 
Chronic UVA and UVB exposure gives rise to cutaneous immunosuppression and DNA 48 
damage, which together form the intrinsic pathways to NMSC photocarcinogenesis (7). The 49 
UVA wavelength penetrates into the dermis of skin and is predominantly responsible for the 50 
photoaging effects of sun exposure (8). Thought to be the major causative factor in epidermal 51 
malignancies, UVB is known to be highly destructive to keratinocytes via direct DNA 52 
damage (9). UVB-irradiation leads to the formation of DNA photolesions, predominantly 53 
cyclobutane pyrimidine dimers (CPDs) and (6-4) pyrimidine-pyrimidones, together with the 54 
generation of DNA-damaging reactive oxygen species (10). Defence mechanisms against 55 
cutaneous photocarcinogenesis include the activation of cell cycle arrest and the subsequent 56 
initiation of the nucleotide excision repair complex (11). Failure to correctly and completely 57 
repair UVR-induced DNA damage, however, can lead to the accumulation of signature 58 
mutations, such as C→T transitions, commonly found in UVR-induced skin tumours (12). 59 
Higher doses of UVB radiation trigger apoptosis (or the formation of sunburn cells), yet 60 
another cellular safety net to inhibit the replication of genetically-damaged proliferative 61 
keratinocytes (13). The intricacies of keratinocyte responses to UVB, and in particular the 62 
processes surrounding NMSC formation, however, have yet to be fully mapped. 63 
Investigations into the biological reactions following UVB radiation exposure using human 64 
participants have several ethical constraints. These are attributed to the considerable risks 65 
involved with UVR exposure and the requirement of skin biopsy collection, which together 66 
have limited such studies. Hence, physiologically-relevant in vitro experimental platforms 67 
capable of accurately modelling the human UVB epidermal response may represent a 68 
practical and accessible alternative to such in vivo studies. 69 
A variety of animal, cell and tissue culture-based models have been employed to investigate 70 
UVB-induced damage and repair in keratinocytes (14). Drawbacks associated with these 71 
techniques, however, include strict ethical regulations, significant costs and inconsistencies 72 
relating to structural and biological aspects of native skin (15-17). The establishment of 3-73 
dimensional (3D), tissue-engineered, organotypic human skin equivalents (HSEs) has 74 
addressed some of these limitations (15, 18, 19). Essentially, the construction of HSEs 75 
involves the culture of epidermal skin cells on natural or synthetic dermal substrates. These 76 
HSEs may then be cultured at the air-liquid interface in order to promote keratinocyte 77 
differentiation and epidermogenesis (20-22). This results in the formation of an epidermal 78 
layer that is histologically similar to native human skin (21). These tissue-engineered 79 
constructs serve as versatile and powerful research tools with numerous applications, such as 80 
the study of cancer, pigmentation and toxicity (23). 81 
In this study, we characterise the novel application of a human keratinocyte-based HSE using 82 
a de-epidermised dermal (DED) culture substrate as a tool to investigate keratinocyte 83 
responses to UVB radiation. Importantly, compared to conventional 2D keratinocyte cultures, 84 
the HSE-DED more closely recapitulates the in vivo tissue structure and microenvironment 85 
(24, 25). The use of synthetic dermal substrates like collagen (26), fibrin (27) and chitosan-86 
gelatin-hyaluronic acid (28) in HSE construction has shown mixed results in terms of 87 
keratinocyte attachment and differentiation (29, 30). Moreover, countries such as Australia 88 
tightly regulate the import of commercially-available HSE composites for research purposes 89 
(25). Hence, the aim of this study was to validate the HSE-DED model as an accessible and 90 
biologically-compatible platform to study UVB radiation-induced damage and post-91 
irradiation repair in keratinocytes. 92 
This HSE-DED model has been established in our laboratory as a tool to study wound 93 
healing and re-epithelialisation processes (20, 21). Herein, we describe an additional 94 
application of the HSE-DED to characterise the epidermal UVB photoresponse in vitro. 95 
Specifically, the HSE-DED was validated in terms of: (1) the expression of key epidermal 96 
differentiation markers compared to native skin; (2) the generation of characteristic markers 97 
of UVB photodamage and (3) the capacity for post-irradiation repair and regeneration on 98 
cellular and epidermal tissue levels. 99 
  100 
Materials & methods 101 
Isolation and culture of human keratinocytes 102 
Human keratinocytes were isolated from skin tissue obtained from surgical discard as 103 
previously described (31). Briefly, skin was washed in three serial washes with antibiotic-104 
antimycotic solution (Invitrogen) supplemented with gentamicin sulphate. Skin tissue was cut 105 
into approximately 3 x 3 mm pieces and incubated in 0.125% trypsin solution at 4°C 106 
overnight. Following enzymatic digestion, the epidermis was detached from the dermis using 107 
forceps. Cells at the epidermal-dermal junction were scraped off gently and resuspended in 108 
Full Green’s media (FGM) as described previously by Rheinwald and Green (24, 32, 33).  109 
Freshly isolated epidermal cells were then seeded into a T75 cell culture flask containing 2 x 110 
10
6
 irradiated 3T3 mouse fibroblasts at a ratio of 1:1. Keratinocyte cultures were maintained 111 
at 37°C with 5% CO2 until 80% confluency was reached. Cell culture media (FGM) was 112 
replaced every 2-3 days. Non-sun exposed skin was obtained from consenting donors 113 
undergoing elective cosmetic breast reduction or abdominoplasty procedures. Ethical 114 
approval for the collection of human tissue was obtained from ethics committees at 115 
participating hospitals and the Queensland University of Technology (St Andrew’s Hospital; 116 
Approval #200 4/46, Brisbane Private Hospital and Princess Alexandra Hospital; Approval 117 
#QUT 3865H). All experimentation performed with donor tissue was in accordance with the 118 
Declaration of Helsinki, 2004.  119 
Preparation and culture of HSE-DED 120 
The HSE-DED composites were prepared using a previously reported method (22). Briefly, 121 
the DED scaffold was prepared from 1.4 cm
2
 piecesthe dermis of ex vivo skin tissue 122 
according to previously described protocols (22, 24) by immersion in 1 M sodium chloride 123 
solution and incubated at 37°C overnight to decellularise the tissue. The epidermis was then 124 
separated from the dermal tissue and discarded. Next, approximately 1.4 cm2 pieces of DED 125 
were prepared in 24-well cell culture plates (Thermo Fischer Scientific, Waltham, MA, 126 
USA). The resulting de-epidermised dermis (DED) was then washed with phosphate buffered 127 
saline before being immersed in FGM overnight at 37°C prior to keratinocyte seeding.  128 
Cultured keratinocytes (passage 1, 2 x 10
4
 cells) were then seeded (in sterile stainless-steel 129 
rings with silicone washer bases, (Aix Scientifics, Aachen, Germany) onto the papillary 130 
surface of each prepared DED. The DED was then incubated with the rings in place at 37°C 131 
with 5% CO2 for 48 hours prior to their removal. The HSE-DED composites were then 132 
cultured in FGM on stainless-steel grids at the air-liquid interface in 6-well cell culture plates 133 
(Thermo Fischer Scientific) at 37°C with 5% CO2, for nine days (21).  134 
UVB-irradiation of skin tissues 135 
Skin tissues (HSE-DEDs and ex vivo skin explants) were irradiated with a single dose of 136 
UVB radiation using a calibrated medical UVB bulb (TL-40, Phillips) calibrated to deliver 137 
9.27 mJ/cm
2
/min UVB radiation, with a stabilised power supply under sterile conditions in 138 
the dark at room temperature. Cellulose acetate film (Kodacel TA-407, Eastman-Kodak) was 139 
used to block out contaminating radiation (wavelengths below 290 nm) from the UVB source 140 
(34). The HSE-DED constructs were partially submerged in pre-warmed PBS during 141 
irradiation. In the irradiated samples, the epidermal surface of HSE-DED constructs were 142 
placed 6cm from the external surface of the UVB lamp and exposed to 50 mJ/cm2 UVB (2 143 
minimum erythemal dose) radiation. Irradiation was conducted inside a Class II Biological 144 
Safety Cabinet to maintain sterility. Mock irradiated samples were treated with similar 145 
conditions but in the absence of UVB radiation. The UVB irradiation dose was chosen based 146 
on dose-response studies in which 50 mJ/cm
2
 UVB generated classic markers of UVB 147 
radiation-induced damage without complete destruction of the HSE-DED epidermal layer 148 
(data not shown). The skin equivalent constructs were returned to the culture conditions as 149 
described in the previous section post-irradiation. Ex vivo skin explant tissues used for 150 
comparative analysis were UVB-irradiated within 2 hours of excision from the donor patient. 151 
The skin explant tissues were maintained in Full Green’s media on stainless-steel grids at the 152 
air-liquid interface in 6-well cell culture plates (Thermo Fischer Scientific) at 37°C with 5% 153 
CO2 until analysis. 154 
Histological analysis 155 
At specific time points post-irradiation, HSE-DED composite tissue was fixed in 10% neutral 156 
buffered formalin overnight at 4°C, before being dehydrated in a graded ethanol series and 157 
paraffin-embedded. Sections of 5 µm thickness were cut (from the centre of the HSE-DED 158 
samples) and mounted onto glass slides. The tissue sections were deparaffinised in xylene 159 
and rehydrated in a decreasing graded ethanol series prior to routine haematoxylin and eosin 160 
(H&E) staining. 161 
Immunohistochemical analysis 162 
The immunohistochemical analyses of the HSE-DED tissue sections were performed as per 163 
previously documented techniques (22). Briefly, 3 µm thick tissue sections were 164 
deparaffinised and rehydrated prior to heat-induced epitope revival treatment in either tris-165 
ethylendiaminetetraacetic acid (EDTA) buffer at pH 9.0 or sodium citrate buffer at pH 6.0 for 166 
4 minutes at 97°C, followed by 10 minutes at 70°C in a decloaking chamber. Endogenous 167 
peroxidases were blocked with hydrogen peroxide solution (Biocare Medial, Pike Lake, CA, 168 
USA) and non-specific primary antibody binding was blocked using a blocking reagent 169 
(Biocare Medical). The primary antibodies used in immunohistochemical analysis are 170 
detailed in Table 1. Primary antibodies were diluted in sample diluent solution (Biocare 171 
Medical) and incubated in a humidified chamber overnight at 4°C. A horse-radish peroxidase 172 
linked secondary antibody was then applied to the tissue samples and detected with  a 173 
3,3’diaminobenzidine (DAB) chromogen system (Biocare Medical). The tissue sections were 174 
counterstained using haematoxylin Gill 1 (G1) nuclear stain (HD Scientific). 175 
Fernandez. Table 1.doc 176 
Primary antibodies used in immunohistochemical analysis 177 
Detection of apoptotic cells 178 
Tissue sections of UVB-irradiated HSE-DED composites were analysed for the presence of 179 
apoptotic cells using an in situ terminal deoxynucleotidyl transferase dUTP nick end labelling 180 
(TUNEL) assay (Roche Applied Science, Penzberg, Germany) as per the manufacturer’s 181 
protocol. Cell nuclei were counterstained with DAPI solution (Invitrogen, Carlsbad, 182 
California) and imaged using fluorescence microscopy. 183 
Quantification of secreted cytokines 184 
To quantify levels of secreted cytokines in UVB-irradiated HSE-DED cultures, enzyme-185 
linked immunoassay kits (Quantikine®, R&D Systems, MN, USA) for the detection of 186 
human IL-6 and IL-8 were utilised as per the manufacturer’s instructions. Before irradiation, 187 
Full Green’s media was replaced with serum-free media (Full Green’s media without foetal 188 
calf serum) in the HSE-DED cultures. Cell culture supernatant samples were collected prior 189 
to and after UVB irradiation and were centrifuged to remove cellular debris. Samples were 190 
stored at -80°C until the assay was performed. 191 
Image analysis 192 
Digital image analyses of antibody-labelled tissue sections were performed using ImageJ 193 
software (public domain software downloaded from http://rsb.info.nih.gov/ij/) (35). 194 
Statistical analysis 195 
One-way ANOVA with Tukey's post hoc tests (all group comparisons) was applied to 196 
analyse the data. Statistical significance was accepted when p<0.05. 197 
198 
Results 199 
Epidermal characterisation of the HSE-DED model compared to native skin 200 
The human epidermis has a characteristic polarized pattern of keratinocyte growth, with 201 
actively proliferating cells situated at the dermal-epidermal junction. A comparative 202 
immunohistochemical study was conducted on unirradiated HSE-DED and native skin tissue 203 
to identify parallels in the expression of key epidermal markers (Figure 1). Keratins 1, 10 and 204 
11 were detected in terminally-differentiated keratinocytes within the stratum spinosum, 205 
stratum granulosum and stratum lucidum in both the HSE-DED and ex vivo skin sections. 206 
Upper spinous and granular keratinocytes, known to express cytokeratin 2e, were also 207 
detected in the HSE-DED composites (36, 37). Similarly, the presence of keratin 14-208 
expressing keratinocytes was detected in both native skin and HSE-DED sections, with 209 
higher immunoreactivity levels observed among the basal and suprabasal cell populations. 210 
Positive immunoreactivity of filaggrin was detected in the cornified envelope of 211 
keratinocytes within the stratum corneum in both the HSE-DED and skin tissue samples 212 
alike. The presence of type IV collagen, a major constituent of the BM zone in skin, was 213 
detected at the dermal-epidermal junction in both the HSE-DED and skin tissue samples. 214 
Besides separating the epidermis and dermis, collagen IV is also known to line sweat glands, 215 
hair follicles and blood vessels, which accounts for its positive immunoreactivity in these 216 
structures within the dermis and DED (38). 217 
 218 
Figure 1. Characterisation of unirradiated HSE-DED constructs compared to native skin. H&E staining of HSE-219 
DED and native skin sections (A) shows histological parallels between the two tissue types. The expression of 220 
epidermal markers in the HSE-DED and ex vivo skin was analysed using immunohistochemistry (brown 221 
staining). Keratins 1/10/11 (B) were detected in the stratum spinosum, stratum lucidum and stratum granulosum 222 
in both samples. The expression of cytokeratin 2e (C) was observed in upper suprabasal keratinocytes in both 223 
the HSE-DED and skin sections. Filaggrin (D)  expression was detected in the stratum corneum layer in both ex 224 
vivo and skin equivalent tissues. Keratin 14 (E) appeared in basal and suprabasal keratinocytes in both sections 225 
of HSE-DED and native skin, with the latter showing a more intense immunoreactivity in the stratum basal. 226 
Collagen IV (F) was observed at the epidermal-dermal junction and lining dermal structures in both the skin 227 
equivalents and native skin. Images are representative of immunohistochemical analyses of native skin and 228 
HSE-DED constructs from three independent skin donor samples. Scale bars represent 50 µm in length. 229 
 230 
UVB irradiation induces markers of photodamage in the HSE-DED  231 
Histological analysis of UVB-irradiated HSE-DED and ex vivo skin explant tissue revealed 232 
the formation of apoptotic keratinocytes in the epidermal layer, characterised by the presence 233 
of pyknotic nuclei and cytoplasmic shrinkage (Figure 2A). The formation of CPD molecular 234 
lesions in the nuclei of UVB-irradiated keratinocytes is a classic biomarker of DNA damage 235 
and an important factor in NMSC development (10). Immunohistochemical staining using an 236 
antibody specific for CPDs was performed on irradiated and non-irradiated HSE-DED tissue 237 
(Figure 2B). CPD-positive keratinocytes were observed only in UVB-treated HSE-DED 238 
constructs, showing marked positive nuclear immunoreactivity in basal and suprabasal cells. 239 
 240 
 241 
Figure 2. Analysis of UVB photodamage markers in irradiated HSE-DED constructs. Images represent the 242 
histology (A), formation of cyclobutane pyrimidine dimers (CPDs) (B), apoptotic keratinocytes (C) and p53 243 
expression (D) in sections of HSE-DED exposed to 2 MED UVB radiation. At 24 hours post-irradiation, 244 
sections of the irradiated HSE-DED constructs appear histologically similar to that of irradiated ex vivo human 245 
skin. Immediately after UVB exposure, the presence of DNA dimers (B) within the nuclei of HSE-DED 246 
keratinocytes is shown by the immunohistochemical detection of CPDs. Sunburn cells or apoptotic 247 
keratinocytes were detected in irradiated HSE-DED using the TUNEL assay and immunofluorescence. The 248 
presence of sunburn cells (green fluorescence) was observed in the epidermal layer of irradiated HSE-DED (C) 249 
at 24 hours after UVB exposure. The expression of p53, an important cellular mediator of UVB-induced 250 
pathways was analysed at 3, 6 and 24 hours after irradiation in HSE-DED tissue. As indicated by the arrows, 251 
p53-positive keratinocyte nuclei appear in irradiated HSE-DED constructs after 3, 6 and 24 hours post-252 
irradiation. 253 
Keratinocytes that have sustained irreparable DNA damage resulting from UVB damage 254 
undergo apoptosis to prevent the propagation of cells harbouring photolesions. Using the 255 
TUNEL assay, DNA fragmentation (as a marker of apoptosis) was detected in UVB-exposed 256 
HSE-DED constructs (Figure 2C). At 24 hours after a single 2 MED UVB dose, cells 257 
undergoing apoptosis were found to be present along the stratum basale and among 258 
suprabasal keratinocyte populations. On average, 19.9 ± 4.1% of the total number of 259 
epidermal nuclei were found to be TUNEL-positive at 24 hours post-irradiation. 260 
The activation and downstream processes mediated by p53 are known to be critical for 261 
suppressing oncogenesis in UVB-irradiated keratinocytes. The presence of p53 in UVB-262 
exposed HSE-DED keratinocytes was detected using immunohistochemical analysis (Figure 263 
2D). Sections from these HSE-DED constructs sacrificed at 0, 3, 6 and 24 hours post-264 
irradiation reveal the intranuclear accumulation of p53.  265 
The upregulation of IL-6 and IL-8 production by UVB-irradiated keratinocytes are thought to 266 
be central catalysts for the activation of local and systemic immune responses (39, 40). The 267 
relative levels of secreted IL-6 and IL-8 were quantified in the media of HSE-DED cultures 268 
before and after UVB exposure with an ELISA (Figure 3). Increases in the production of both 269 
cytokines were observed in irradiated HSE-DED at the 24 hour post-irradiation time-point 270 
compared to samples obtained at t=0 hours. This includes a significant increase from 1.00 ± 271 
0.3 pg/mL to 90.3 ± 16.8 pg/mL in detected IL-6. Basal levels of IL-8 detected were 272 
relatively higher (24.0 ± 1.0 pg/mL) due to this cytokine being constitutively expressed by 273 
keratinocytes. UVB exposure resulted in a slight increase in IL-8 in HSE-DED media, with 274 
an average of 66.1 ± 5.7 pg/mL. 275 
 276 
 277 
Figure 3. Quantification of cytokine secretion in HSE-DED culture supernatants. Cell culture medium samples 278 
were obtained from HSE-DED cultures prior to and 24 hours after irradiation with 2 MED UVB radiation. 279 
Supernatants were analysed for the presence of interleukin-6 (A) and 8 (B) (IL-6/8) using an ELISA method. 280 
Data represents the average quantities of IL-6 and IL-8 detected at the two time points (mean ± SEM), in 281 
experimental triplicates from two independent skin donors, expressed in pg/mL. All measurements were 282 
normalised to total protein levels in culture supernatants. Asterisks represent statistical significance (p<0.05) in 283 
the difference between matched samples at t=0 hr. 284 
HSE-DED composites retain the capacity for repair and regeneration after UVB irradiation 285 
Due to the frequency of their exposure to damaging UVR, keratinocytes possess highly 286 
sophisticated repair mechanisms to cope with the formation of UVB-induced DNA mutations 287 
(41). The efficient removal of CPDs, for instance, has been strongly associated with the 288 
prevention of oncogenic transformation in irradiated keratinocytes (42). In view of this, 289 
immunohistochemical analysis was performed to study the removal of UVB-induced CPDs in 290 
irradiated HSE-DED composites (Figure 4A). After a single dose of UVB radiation, a gradual 291 
decrease in the intensity of CPD-positive immunoreactivity was observed in the epidermis of 292 
the HSE-DED over five days under culture conditions. At two to five days post-irradiation, a 293 
significant decrease in the number of CPD-bearing keratinocytes were observed in these 294 
constructs as compared to levels immediately following UVB exposure (Figure 4B). 295 
 296 
Figure 4. Post-irradiation removal of UVB-induced CPDs in HSE-DED constructs. Cyclobutane pyrimidine 297 
dimers (CPDs) in the nuclei of HSE-DED keratinocytes irradiated with 2 MED UVB over five days were 298 
detected using immunohistochemical analysis (A). The HSE-DED constructs were then returned to culture 299 
conditions and sampled every 24 hours to test for the presence of UVB-induced DNA damage. From Days 0 to 300 
5 after UVB exposure, there was an observable decrease in the number of CPD-positive keratinocytes in the 301 
epidermal layer of the HSE-DED. Keratinocytes harbouring CPDs in the HSE-DED post-irradiation were 302 
quantified using image analysis (B). The graph represents the mean ratio of immunopositive cells to total cell 303 
nuclei in five microscopy fields per sample ± SEM. At Days 2 to 5, there was a statistically-significant (p<0.05) 304 
decrease in the proportion of CPD-positive cells (compared to Day 0). The data presented is representative of 305 
results obtained using three independent tissue donors (n=3). HSE-DEDs were constructed in triplicates for each 306 
time point sampled. 307 
 308 
Epidermal regeneration following UVB-induced damage is facilitated by the stimulation of 309 
proliferation by various growth factors and cytokines (43). The nuclear expression of the Ki-310 
67 antigen occurs during all active phases of cellular proliferation (44). Keratinocyte 311 
proliferation during the HSE-DED epidermal regenerative phase was investigated using 312 
immunohistochemical detection of Ki-67 in tissue sampled over five days post-irradiation 313 
(Figure 5). In UVB-exposed HSE-DED constructs, significantly lower numbers of Ki-67-314 
expressing keratinocytes were observed at one and two days after irradiation (relative to 315 
unexposed HSE-DEDs). Subsequently, at three and four days post-treatment, there was a 316 
significant elevation in the number of proliferative keratinocytes in the UVB-treated 317 
constructs as compared to the untreated controls. Similar levels of Ki-67-positive 318 
keratinocytes were observed at Day 0 and Day 5 in both irradiated and non-irradiated 319 
samples. This indicates that UVB exposure triggers an initial inhibition of proliferation in the 320 
HSE-DED keratinocytes, potentially coinciding with the repair of DNA damage. This is 321 
followed by a proliferative burst which may function to replace UVB-damaged cells in which 322 
differentiation or apoptotic pathways have been activated. 323 
 324 
Figure 5. Analysis of keratinocyte proliferation in HSE-DED constructs. The proliferation marker, Ki-67 was 325 
detected using immunohistochemistry in 2 MED UVB-irradiated and non-irradiated control HSE-DED 326 
constructs (A). Following UVB exposure or sham irradiation, the HSE-DEDs were returned to culture 327 
conditions and sampled every 24 hours for five days to investigate changes in epidermal proliferation during this 328 
period. Keratinocyte nuclei positive for Ki-67 are in the active phases of the cell cycle. The images presented 329 
are representative of experimental triplicates from three independent skin donors. The scale bar represents 50 330 
µm. 331 
 332 
Another physiological epidermal response to UVR exposure is the thickening of the stratum 333 
corneum, which together with the tanning, is thought to be a protective mechanism (45). This 334 
increase in thickness is associated with elevated levels of keratinocyte differentiation into 335 
corneocytes (46). The layer of differentiated keratinocytes (expressing keratins 1/10/11) in 336 
the HSE-DED epidermis was investigated subsequent to UVB exposure via 337 
immunohistochemistry to identify whether similar processes occur in these constructs (Figure 338 
6). These areas were then quantified using image analysis software. In the first three days 339 
following UVB irradiation, a decline in the average immunoreactive areas to keratins 1/10/11 340 
was observed. This was localised to the spinous and granular layers of the epidermis. This 341 
was accompanied by a thickening of the stratum corneum layer in these constructs as 342 
observed in the tissue sections. Similar results of UVB-induced epidermal thickening have 343 
also previously been reported from in vivo studies involving irradiated test subjects (47, 48). 344 
  345 
 346 
Figure 6. Epidermal blistering and regeneration after UVB irradiation in HSE-DED constructs. 347 
Immunohistochemical staining of keratin 1/10/11 in irradiated and mock-irradiated HSE-DED was conducted to 348 
identify changes to the thickness of the  suprabasal layer containing differentiated keratinocytes (A). The images 349 
presented are representative of experimental triplicates from three independent skin donors. The scale bar 350 
represents 50 µm. The area of keratin 1/10/11 expression within the epidermis from immunohistochemical 351 
analysis was then quantified using image analysis software (ImageJ) (B). The mean area of keratin 1/10/11 352 
positive immunoreactivity was expressed in µm2 from five microscopy fields in three independent experiments. 353 
The mean area of the stratum corneum layer was also quantified using image analysis (C). UVB irradiation 354 
causes a significant thickening of the HSE-DED stratum corneum. Error bars represent SEM values. Asterisks 355 
represent statistically significant differences (p<0.05) as compared to the non-irradiated controls at the same 356 
time point. Experiments were conducted on samples from three independent skin tissue donors. 357 
  358 
Discussion 359 
The gold standard of in vitro photobiology models should display biological parallels with 360 
native skin, as well as classical photodamage markers upon UV irradiation. Conventional 361 
cell-based techniques, such as 2D cultures, do not adequately represent the complex 362 
morphology and organisational aspects of the human epidermis. Moreover, limitations 363 
associated with animal models include ethical restrictions, high costs and differences to 364 
human skin anatomy and physiology. Accordingly, the HSE-DED reconstituted skin model 365 
constructed herein was validated as an experimental model to investigate keratinocyte 366 
responses to UVB radiation. Composed of primary human keratinocytes cultured on a DED 367 
dermal substrate, the HSE-DED constructs maintains histological and physiological aspects 368 
of native skin, many of which are critical to the UVB photoresponse. Previously, we have 369 
reported that the 3D HSE-DED organotypic model can be applied to the investigation of a 370 
diverse range of epithelial processes including wound-healing (22, 49). In this current study, 371 
UVB irradiation of the HSE-DED was found to induce the generation of characteristic 372 
markers of photodamage in human keratinocytes. Significantly, our data indicates that the 373 
HSE-DED keratinocytes also retained their capacity to repair during epidermal regeneration 374 
post-irradiation. 375 
Histological analysis of the HSE-DED revealed several morphological features of the native 376 
epidermis, such as the presence of rete ridges and the epidermal structural organisation, were 377 
retained. This was in accordance with previously-reported studies on the histology of similar 378 
tissue-engineered skin constructed in vitro (50-52). The use of similar HSE models has also 379 
been reported in studies into UVR-induced alterations to epidermal viability (53) and protein 380 
expression (54). In these models, different dermal substrates such as collagen matrices, as 381 
well as various combinations of UVR wavelengths and doses were utilised. Importantly, to 382 
date, a fully characterised model using reconstituted human tissue is still lacking. By 383 
incorporating a single cell type into the HSE-DED model described herein, we aimed to 384 
obtain baseline data on the effects of UVB radiation in a physiologically-relevant setting. 385 
This can then be used to compare, for example, the protective effects of other cutaneous cell 386 
populations, such as melanocytes and fibroblasts, upon their incorporation into the HSE 387 
model. 388 
The presence of a multilayered epithelium with a polarised differentiation gradient was 389 
further confirmed in the HSE-DED via the immunohistochemical detection of keratins 14, 390 
1/10/11, 2e and filaggrin. Importantly, the HSE-DED allows for the investigation into 391 
specific responses of basal keratinocytes to UVB radiation, in the context of a differentiated 392 
epidermis. Indeed, damage to DNA in basal keratinocytes as a result of UVB exposure is 393 
thought to be a major initiating factor in the development of SCC and BCCs (3). The 394 
protective function of the stratum corneum and filaggrin-expression in the HSE-DED 395 
epidermis is also significant in the modelling of UVB-induced epithelial damage (55-57). 396 
Monolayer and tissue-engineered cultures lacking filaggrin, for example, have elevated levels 397 
of DNA damage and apoptosis observed in the stratum basale (57). Additionally, the positive 398 
identification of the basement membrane component, collagen IV, at the epidermal-dermal 399 
junction is notable as a physiologically-relevant photobiology model. Lacking in 2D cell 400 
cultures, such BM components have been found to profoundly influence keratinocyte 401 
responses to many external stimuli, including UVB radiation (58, 59).  402 
The classical markers of acute cutaneous photodamage have been well-documented, and 403 
include the formation of DNA photolesions, apoptosis, inflammation and the tanning 404 
response (60). Notably, in the studies reported here, key UVB-induced keratinocyte damage 405 
markers were shown to be inducible in the HSE-DED in an in vitro setting. The formation of 406 
CPDs and other photoproducts are a fundamental mutagenic event in the transformation of 407 
basal keratinocytes (3). In the HSE-DED, irradiation was found to result in the formation of 408 
these thymine dimers in keratinocyte nuclei, in line with investigations on UVB-exposed 409 
native skin biopsies (61, 62). Interestingly, the rate of CPD-removal in the HSE-DED was 410 
comparable not only to studies using other organotypic skin constructs, but also to the above-411 
mentioned in vivo experiments (52, 63). This indicates that the cells in the HSE-DED retain 412 
the ability to initiate DNA damage response and repair pathways, which potentially allows 413 
for the screening of novel mechanisms to enhance these processes. 414 
The activation of both DNA damage-induced apoptosis and repair mechanisms are highly-415 
dependent on the function of p53 (64-66). The UVB-induced accumulation of p53 in HSE-416 
DED basal and suprabasal keratinocytes correlates with previously documented reports (67) 417 
(66). Importantly, major differences in p53 activation have been identified between irradiated 418 
keratinocyte monolayers and in vivo skin (68). This has been attributed to factors such as 419 
keratinocyte differentiation status and cellular adhesion (69). The UVB-triggered secretion of 420 
inflammatory cytokines, including IL-1, -6, -8, -10, -12 and tumour necrosis factor-α 421 
stimulate erythemal and immunomodulatory responses post-irradiation (70-73). In line with 422 
earlier reports, our data demonstrates a significant augmentation of IL-6 and IL-8 levels in 423 
HSE-DED culture media following from UVB irradiation (39, 40). Potentially, the irradiated 424 
HSE-DED model could thus be applied to the analysis of pathways involved in inflammation 425 
as a result of UV-exposure or cutaneous diseases such as psoriasis (74, 75).  426 
Several previous studies on keratinocyte responses to irradiation involve the use of non-427 
physiological doses of UVB to induce photodamage (76, 77). In part, this is because 428 
monolayer keratinocyte cultures are selective for cells with a more proliferative phenotype 429 
and an associated higher tolerance to UVB-induced damage (78). Moreover, the use of 430 
pigmented skin equivalents has been shown to withstand higher UVB doses; this is due to the 431 
shielding effect of melanin (79-81). Similarly, other in vivo studies in pigmented skin show 432 
relatively lower levels of apoptosis-induction following irradiation compared to those 433 
observed in the HSE-DED (82). The studies reported herein characterising the HSE-DED 434 
model were conducted using physiological doses of UVB radiation. Indeed, the doses utilised 435 
have previously been reported to be experienced within the Australian population (83, 84). 436 
The HSE-DED, therefore, may be applied to the testing of potential therapeutics or 437 
preventative strategies against keratinocyte damage in a biologically-appropriate setting. 438 
In summary, we demonstrate here that the HSE-DED model holds potential as a versatile and 439 
powerful photobiology tool due to the retention of several physiological cutaneous properties. 440 
Moreover, the HSE-DED represents a basic epidermal model into which additional cell types 441 
can be incorporated resulting in the creation of an improved biologically-relevant skin model. 442 
It is important to bear in mind that despite the HSE-DED model being flexible in terms of the 443 
origin and type of primary cells that may be incorporated, this may also contribute to inter-444 
donor variability, a phenomenon that has been reported in a variety of skin studies (85-87). 445 
Indeed, studies have shown variability to exist, particularly in keratinocyte UVB-responses 446 
between individuals (88). In the future, the development of increasingly elegant synthetic 447 
dermal substitutes may provide improved dermal scaffolds which can reduce variability while 448 
preserving the physiological properties of the dermis more faithfully (19, 26-28). 449 
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